Metformin has also been shown to inhibit lipid accumulation and fibrosis in the kidneys of mice with nephropathy, and to increase fatty acid oxidation via modulation of Acetyl-CoA carboxylase by AMPK (Lee et al., 2018). This evidence concerns the gene PRKAA2 and kidney disorder.